The product
TTP creates automated delivery device solutions to reduce the cost and inconvenience of clinical trials. As well as developing products for pharma clients we have also developed and patented our own technology – the Electronic Lung™ breath simulator, for testing inhaler performance

TTP’s role

Developed complete system to predict real-world inhaler performance across a wide range of users. Includes a high precision inspirometer specifically designed to work with the Electronic Lung

What makes it different?

  • Accurately predicts authentic patient breath profiles, providing a powerful tool for predicting lung deposition across a range of populations
  • Reduces risks for clinical trials - gives a valuable insight into in vivo performance at an early stage in the drug development cycle
  • Results can be included in regulatory submissions to demonstrate inhalation performance